Research, evaluation and insight

Scottish Enterprise’s (SE’s) below £100,000 R&D Grant and Innovation Support Grant (ISG) are aimed at increasing R&D and innovation activity in the Scottish company base.

Energy markets are not only vast, but can change very quickly and very dramatically.

This report discusses the broad issues and challenges in assessing the benefits to an economy of economic development spending; such as business support, infrastructure development, inward investment and sector development.

Scottish Food and Drink (SF&D) was established as an industry-led membership organisation which aimed to bring together the whole supply chain involved in the food and drink industry in Scotland under a common strategy and purpose to support industry growth.

The Scottish Bioinformatics Forum (SBF) is designed to raise awareness, promote collaboration and enhance the life sciences sector in Scotland.

Scottish Enterprise (SE) commissioned EKOS to undertake a desk-based economic impact assessment of the RAF Leuchars airbase in Fife, in light of the recent Strategic Defence Review and speculation that the base may be considered for closure.

The aim of the research was to investigate the different condition monitoring techniques that may be applicable for wind turbines, explore their potential application in wind turbines, and examine the relative costs and benefits of condition monitoring systems for wind turbines.

The report aims to provide ITI Scotland members with information about the market and technology associated with blades for offshore wind turbines, in order to help support and advance the design and development of the optimal offshore wind turbine blade.

This paper examines the key issues affecting the market for Electric Vehicles (EVs) & Hybrid Electric Vehicles (HEVs) and the novel technologies being developed to address their current drawbacks.

This report provides a summary of ITI Energy’s initial foresighting study focused on the mature oil and gas assets (MOGA) market.

The report aimed to assess the market and potential for non-grid micro-generation products sized 10 kW and below.

This study maps out and reviews development trends in the power electronics market with the purpose of identifying future opportunities for new technology development, which ITI Energy could seek to invest in.

This report summarises the status of the first generation of biofuels and reports on the ongoing development of the second generation, with particular focus on marine algae as an alternative source of biomass that is now capable of delivering upon its potential.

Biofuels are a renewable natural fuel source which have the potential to serve as alternative to fossil based fuels.

This report provides market intelligence into the sector defined as advanced robotics by the Intermediary Technology Institute (ITI) in Techmedia.

This document provides market intelligence on the concept of Energy Management in the Built Environment (EMBE).

This document provides market intelligence into the sector defined as homeland security by the Intermediary Technology Institute (ITI) in Techmedia.

This document provides market intelligence into the sector defined as nanotechnology by the Intermediary Technology Institute (ITI) in Techmedia.

This document provides market intelligence into the sector defined as remote health by the Intermediary Technology Institute (ITI) in Techmedia.

Safe and inexpensive hydrogen (H2) storage is essential for the development of H2 as a commercially viable energy vector.

Genetic modification (GM) of plants aims to introduce trait-related genes through the genetic engineering of plant material.

Biofuels, a renewable natural fuel source, has the potential to: serve as an alternative to fossil fuels; meet climate change commitments; and reduce reliance on fossil fuels and dependence on foreign oil imports.

A clinical biomarker is defined as a characteristic that is objectively measured and evaluated as indicators of normal biologic or pathogenic processes or pharmacological responses to therapeutic intervention.

Conventional Power Generation (CPG) covers power generation from nuclear and fossil fuels, predominantly coal and natural gas.

Advances in ‘drug delivery’ aim to improve the delivery, performance or safety of a therapeutic product.